EBITDA: Income before interest, taxes, depreciation and amortization.
IR Biosciences Holdings Inc. (IRBS) had EBITDA of $-0.04M for the most recently reported fiscal quarter, ending 2010-12-31.
| Income Statement Financials | |
-- |
|
$-0.34M |
|
-- |
|
-- |
|
$0.40M |
|
$-0.40M |
|
$0.06M |
|
$-0.35M |
|
$-0.35M |
|
$-0.35M |
|
$-0.34M |
|
$-0.34M |
|
$-0.35M |
|
$-0.40M |
|
|
EBITDA |
$-0.04M |
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$0.04M |
|
-- |
|
-- |
|
$0.06M |
|
$6.50M |
|
-- |
|
$0.89M |
|
$7.40M |
|
$-13.31M |
|
$-7.34M |
|
$-7.33M |
|
-- |
|
| Cash Flow Statement Financials | |
$-0.43M |
|
$0.00M |
|
$0.15M |
|
$0.28M |
|
$0.00M |
|
$-0.28M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-- |
|
-0.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2.55% |
|
4.63% |
|
-566.67% |
|
4.64% |
|
-- |
|
-- |
|
-- |
|